AUG 19, 2010
Austrian BIOCRATES Life Sciences AG and Swiss Selexis SA join forces to further optimize high-yield mammalian cell cultures for the production of protein pharmaceuticals
Download the pdf
JAN 05, 2010
Laureate Pharma and Selexis Announce Collaboration
Download the pdf
OCT 12, 2009
Irvine Scientific and Selexis to announce results of successful collaboration
Download the pdf
SEP 22, 2009
Selexis to Develop Antibody Cell Line for Neogenix
Download the pdf
Aug 31, 2009
Selexis and NKT Therapeutics enter into research services agreement
Download the pdf
JUNE 17, 2009
Eden Biodesign and Selexis Announce Continued Cooperation and a Global Joint-Marketing Collaboration
Download the pdf
MAR 31, 2009
Selexis launches Biosimilar Cell Line Development Program
Download the pdf
JAN 07, 2009
Selexis Announces Promotion of Ms. Regine Brokamp to Chief Operating Officer
Download the pdf
SEP 18, 2008
Selexis Enters Into Commercial License Agreement with Merrimack Pharmaceuticals
Download the pdf
SEP 02, 2008
Artelis and Selexis report record antibody production levels in CHO cells of over 31 grams per liter
Download the pdf
JUL 16, 2008
Selexis now offering rapid-development of human cell line with FDA approval pedigree.
Download the pdf
Jun 2, 2008
Selexis’ Licensee to Present at IBC Conference on Power of Selexis Based Cell Line Development Program.
Download the pdf
MAy 7, 2008
Technologies to Improve Cell Line Development - Selexis SA to Present at the BIO2008 in San Diego
Download the pdf
DEC 19, 2007
Selexis Selected as Top Biotech
Download the pdf
NOV 20, 2007
Selexis Announces Promotion of Dr. Pierre-Alain Girod to Chief Scientific Officer
Download the pdf
AUG 21, 2007
Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
Download the pdf
AUG 2, 2007
Selexis Announces License Renewal with Diosynth Biotechnology
Download the pdf
JUL 10, 2007
Selexis Signs Commercial License Agreement with GANYMED Pharmaceuticals
Download the pdf
APR 10, 2007
Selexis Establishes US Subsidiary and Appoints Andrew F. Sandford Vice-President of Business Development and Licensing
Download the pdf
feb 13, 2007
Selexis Expands European Production and Business Operations
New facilities and staff will meet needs of rapidly growing client base, enable continued product innovation
Download the pdf
november 2, 2006
Selexis Receives United States Patent
Patent Covers Methods Used in the Company's SURE Cell Line Development℠ Services and Technology
Download the pdf
July 10, 2006
Selexis to Collaborate with Alpha Biologics on Mammalian Cell Line Development
Alpha Biologics to use Selexis’ SURE Technology Platform to Develop Therapeutic Proteins for Pre-Clinical, Phase I and II Clinical Trials
Download the pdf
June 20 , 2006
Pierre Fabre Enters into License Agreement with Selexis SA to use SURE Technology Platform for Mammalian Cell Line Development
Pierre Fabre Will Use Technology to Research Therapeutic Candidates
Download the pdf
May 30, 2006
Merrimack Pharmaceuticals Enters into License Agreement with Selexis SA to Use SURE Technology Platform for Cell Line Development
Download the pdf
May 23, 2006
Selexis SA Enters Cooperative Agreement with Cambrex Corporation to Use Selexis’ SURE Technology Platform for Mammalian Cell Line Development
Download the pdf
May 5, 2006
Rapid Generation of High Antibody-producer Clones Utilizing Selexis' SURE Technology Platform
Selexis SA to Present at the European Cell Line Development and Engineering Conference
Download the pdf
May 2, 2006
Diosynth Biotechnology Enters into License Agreement with Selexis SA to Use SURE Technology Platform for Commercial Cell Line Development
Download the pdf
April 11, 2006
Selexis SA Enters Into Cooperative Relationship Agreement with Henogen SA
Henogen to Use Selexis Technology Platform for Mammalian Cell Line Development
Download the pdf
March 17, 2006
Selexis SA to Partner at the BIO 2006 Annual International Convention
Selexis to Participate in the Business Forum's One-on-one Partnering Meetings
Download the pdf
February 24, 2006
Case Study Illustrates Cell Specific Productivities of up to 80 pcd Utilizing Bioinformatics and Selexis Patented Technology, MARtech™
Selexis SA to Present Case Study at the Antibody Development and Production Conference
Download the pdf
February 21, 2006
Selexis SA Presented New Data on MARtech™ at the BioProcess International, European Conference and Exhibition
Patented Technology Significantly Improves the Stability of Production Cell Lines
Download the pdf
February 13, 2006
Selexis SA to Present New Data on MARtech™ at the BioProcess International, European Conference and Exhibition
Data Will Elucidate the Mechanism Behind MARtech™
Download the pdf
In order to read this documents you need Acrobat Reader.
If you do not have this software installed, you may download and install it easily and for free clicking here:
